J.B. Richey (left) and Malachi Mixon Invacare (NYSE:IVC) founders Malachi Mixon III and J.B. Richey II have made a $5 million donation to Case Western Reserve University that’s aimed at bolstering the university’s innovation initiatives. The gift will go toward the establishment of a Richey-Mixon Building, which would include space for Case’s school of engineering, […]
A Case Western Reserve University spinoff is planning to commercialize its high-resolution imaging technology that allows preclinical researchers to see the exact location of single cells and displays the information in a 3-D reconstruction of a mouse. Mayfield Village, Ohio-based BioInVision is kicking off the formal marketing launch of its “cryo-imaging” service at the World […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Biomarker company NeoProteomics, a spinoff from Case Western Reserve University, has received a $300,000 grant from the National Institutes of Health. NeoProteomics will use the funding to further refine its bioinformatics software, which is used by clients in the research industry to develop and discover new biomarkers for disease, according to a statement from Case. […]
New research from Case Western Reserve University and two other schools has concluded that problems associated with comparison shopping for health insurance result in small businesses overpaying insurance premiums by an estimated 29 percent. The paper suggests that a major component of last year’s controversial federal health overhaul, insurance exchanges, could help consumers extract better […]
Case Western Reserve University School of Medicine has received a $1.6 million federal grant for research into how tumor cells avoid detection by the body’s immune system. The five-year grant comes from the National Cancer Institute and will help Case researchers examine “immune tolerance,” a process that keeps tumor cells from being detected by the […]
A bioinformatics spinoff company from Case Western Reserve University has reached an exclusive option agreement to license technology from the university. The company, NeoProteomics, was co-founded by Mark Chance, director of Case Center for Proteomics and Bioinformatics. NeoProteomics focuses on the identification and validation of biomarkers, proteins in the blood that can indicate the presence […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Case Western Reserve University's top technology transfer official is resigning from the university to start a new technology transfer and venture development consulting firm. Mark Coticchia's resignation is effective April 1. He joined Case in 2001.
Medical imaging technology company Bioptigen, based in Research Triangle Park, North Carolina, has received a warning that its hand-held imaging device for the eye is being marketed beyond the scope of its 510(k) clearance.
Researchers from Cleveland Clinic and Case Western Reserve University have received a three-year, $3 million grant to study HIV and the body's response in autoimmune diseases.
Case Western Reserve University School of Medicine has received a $7.8 million federal grant to continue a long-term study into bipolar disorders in children.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Stem cell company Athersys completed a study showing its technology could hold therapeutic benefits in treating spinal cord injuries. Researchers found that administering Athersys' MultiStem technology to rodents with spinal injuries reduced inflammation and promoted the regrowth of neurons.
A new Alzheimer's disease biomarker test developed by Durham, North Carolina-based Zinfandel Pharmaceuticals is licensed by Takeda Pharmaceutical Co. in a deal worth up to $87 million.
Case Western Reserve University has received its largest-ever grant for eye research -- $10 million over five years to study retinal disease.
Though the tragic death of noted Alzheimer's researcher Dr. Mark Smith has silenced the voice of one of the leading critics of the so-called amyloid theory, Smith's Case Western Reserve University colleagues expect to carry on his work.
Alzheimer's disease researcher Mark Smith, CWRU School of Medicine professor, was considered a "renegade researcher" for the way he challenged drug companies' assumptions and other conventional wisdom on Alzheimer's. But his opinions were gaining increasing attention, though, particularly after the failure of Eli Lilly's Alzheimer drug in August. He was 45.